<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0000802716</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000053582</seriesId>
        <classId>C000168413</classId>
        <classId>C000168414</classId>
        <classId>C000168415</classId>
        <classId>C000168412</classId>
      </seriesClassInfo>

    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>Victory Portfolios</regName>
      <regFileNumber>811-04852</regFileNumber>
      <regCik>0000802716</regCik>
      <regLei>549300V07N3HJP1EW330</regLei>
      <regStreet1>4900 Tiedeman Road 4th Floor</regStreet1>
      <regCity>Brooklyn</regCity>
      <regStateConditional regCountry="US" regState="US-OH"/>
      <regZipOrPostalCode>44144</regZipOrPostalCode>
      <regPhone>800-539-3863</regPhone>
      <seriesName>Victory RS Science &amp; Technology Fund</seriesName>
      <seriesId>S000053582</seriesId>
      <seriesLei>549300YNZR8S7NDWVW17</seriesLei>
      <repPdEnd>2020-12-31</repPdEnd>
      <repPdDate>2020-06-30</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>381247475.72</totAssets>
      <totLiabs>49130839.58</totLiabs>
      <netAssets>332116636.14</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>10047672.72</cshNotRptdInCorD>
      <curMetrics>
        <curMetric>
          <curCd>USD</curCd>
          <intrstRtRiskdv01 period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
          <intrstRtRiskdv100 period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
        </curMetric>
      </curMetrics>
      <creditSprdRiskInvstGrade period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
      <creditSprdRiskNonInvstGrade period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
      <borrowers>
        <borrower aggrVal="0.00000000" lei="549300F35UE0BOM1WJ55" name="SG AMERICAS SECURITIES LLC"/>
        <borrower aggrVal="579365.00000000" lei="5493001I7IJ4CW6Q9N27" name="CITADEL CLEARING LLC"/>
        <borrower aggrVal="826070.30999999" lei="549300KUN9K9K32C6D97" name="BNP PARIBAS PB INTL LTD"/>
        <borrower aggrVal="0.00000000" lei="549300TDJKVQJ41VN031" name="CIBC WORLD MARKETS INC."/>
        <borrower aggrVal="2874292.55999999" lei="VYVVCKR63DVZZN70PB21" name="WELLS FARGO SECURITIES LLC"/>
        <borrower aggrVal="0.00000000" lei="MRK678VXOI09YSSN8X19" name="TD AMERITRADE CLEARING INC"/>
        <borrower aggrVal="3715.25999999" lei="RCNB6OTYUAMMP879YW96" name="BNP PARIBAS SECURITIES CORP"/>
        <borrower aggrVal="0.00000000" lei="549300445CON3DBMU275" name="CIBC WORLD MARKETS CORP"/>
        <borrower aggrVal="0.00000000" lei="BFM8T61CT2L1QCEMIK50" name="UBS AG LONDON"/>
        <borrower aggrVal="1903630.83999999" lei="L3I9ZG2KFGXZ61BMYR72" name="THE BANK OF NOVA SCOTIA TOR"/>
        <borrower aggrVal="5321190.48999999" lei="MBNUM2BPBDO7JBLYG310" name="CITIGROUP GLOBAL MARKETS INC"/>
        <borrower aggrVal="0.00000000" lei="KB1H1DSPRFMYMCUFXT09" name="WELLS FARGO BANK NA"/>
        <borrower aggrVal="4967874.89999999" lei="9R7GPTSO7KV3UQJZQ078" name="MORGAN STANLEY &amp; CO. LLC"/>
        <borrower aggrVal="809339.22000000" lei="G5GSEF7VJP5I7OUK5573" name="BARCLAYS BANK PLC"/>
        <borrower aggrVal="3281617.05000000" lei="549300HN4UKV1E2R3U73" name="BOFA SECURITIES  INC."/>
        <borrower aggrVal="988114.44000000" lei="AC28XWWI3WIBK2824319" name="BARCLAYS CAPITAL INC"/>
        <borrower aggrVal="10736315.37999999" lei="549300JRHF1MHHWUAW04" name="NATIONAL FINANCIAL SERVICE LLC"/>
        <borrower aggrVal="0.00000000" lei="1V8Y6QCX6YMJ2OELII46" name="CREDIT SUISSE SEC (USA) LLC"/>
        <borrower aggrVal="5588296.00000000" lei="RUC0QBLBRPRCU4W1NE59" name="BMO CAPITAL MARKETS CORP"/>
        <borrower aggrVal="0.00000000" lei="58PU97L1C0WSRCWADL48" name="JEFFERIES LLC"/>
        <borrower aggrVal="2732901.70999999" lei="571474TGEMMWANRLN572" name="STATE STREET BANK AND TRUST CO"/>
        <borrower aggrVal="5548712.25000000" lei="ZBUT11V806EZRVTWT807" name="J.P. MORGAN SECURITIES LLC"/>
        <borrower aggrVal="0.00000000" lei="7TK5RJIZDFROZCA6XF66" name="MIZUHO SEC USA LLC."/>
        <borrower aggrVal="1174582.46000000" lei="ZI8Q1A8EI8LQFJNM0D94" name="PERSHING LLC"/>
      </borrowers>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000168413" rtn1="18.37000000" rtn2="12.59" rtn3="6.74000000"/>
          <monthlyTotReturn classId="C000168414" rtn1="18.38000000" rtn2="12.62000000" rtn3="6.78000000"/>
          <monthlyTotReturn classId="C000168412" rtn1="18.43000000" rtn2="12.61000000" rtn3="6.87000000"/>
          <monthlyTotReturn classId="C000168415" rtn1="18.45000000" rtn2="12.70" rtn3="6.86000000"/>
        </monthlyTotReturns>
        <othMon1 netRealizedGain="403178.92000000" netUnrealizedAppr="42885102.74"/>
        <othMon2 netRealizedGain="1408802.22" netUnrealizedAppr="33459390.84"/>
        <othMon3 netRealizedGain="3157909.99" netUnrealizedAppr="18362448.18"/>
      </returnInfo>
      <mon1Flow redemption="-8421839.88000000" reinvestment="0.00000000" sales="4834088.16000000"/>
      <mon2Flow redemption="-5621931.10000000" reinvestment="0.00000000" sales="4820922.50000000"/>
      <mon3Flow redemption="-5044842.78000000" reinvestment="0.00000000" sales="7752196.49000000"/>

    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>ZoomInfo Technologies Inc</name>
        <lei>N/A</lei>
        <title>ZOOMINFO TECHNOLOGIES INC - A</title>
        <cusip>98980F104</cusip>
        <identifiers>
          <isin value="US98980F1049"/>
        </identifiers>
        <balance>1000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>51030.00000000</valUSD>
        <pctVal>0.015365083963</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arcus Biosciences Inc</name>
        <lei>N/A</lei>
        <title>ARCUS BIOSCIENCES INC</title>
        <cusip>03969F109</cusip>
        <identifiers>
          <isin value="US03969F1093"/>
        </identifiers>
        <balance>49820.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1232546.80000000</valUSD>
        <pctVal>0.371118657085</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Autolus Therapeutics PLC</name>
        <lei>549300C0KZP8EYROLL02</lei>
        <title>AUTOLUS THERAPEUTICS PLC</title>
        <cusip>05280R100</cusip>
        <identifiers>
          <isin value="US05280R1005"/>
        </identifiers>
        <balance>57600.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>923328.00000000</valUSD>
        <pctVal>0.278013173543</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ARENA PHARMACEUTICALS, INC.</name>
        <lei>529900CVGQMPJ3A3NI85</lei>
        <title>ARENA PHARMACEUTICALS INC</title>
        <cusip>040047607</cusip>
        <identifiers>
          <isin value="US0400476075"/>
        </identifiers>
        <balance>18440.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1160798.00000000</valUSD>
        <pctVal>0.349515162351</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="345235.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kalvista Pharmaceuticals Inc</name>
        <lei>529900Q7IDA3WUGRZA51</lei>
        <title>KALVISTA PHARMACEUTICALS INC</title>
        <cusip>483497103</cusip>
        <identifiers>
          <isin value="US4834971032"/>
        </identifiers>
        <balance>53653.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>649201.30000000</valUSD>
        <pctVal>0.195473887591</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.</name>
        <lei>N/A</lei>
        <title>MACOM TECHNOLOGY SOLUTIONS HOL</title>
        <cusip>55405Y100</cusip>
        <identifiers>
          <isin value="US55405Y1001"/>
        </identifiers>
        <balance>227830.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7825960.50000000</valUSD>
        <pctVal>2.356389186328</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Revolution Medicines Inc</name>
        <lei>549300JU3X0LBCQ65892</lei>
        <title>REVOLUTION MEDICINES INC</title>
        <cusip>76155X100</cusip>
        <identifiers>
          <isin value="US76155X1000"/>
        </identifiers>
        <balance>9660.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>304966.20000000</valUSD>
        <pctVal>0.091825029767</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Editas Medicine Inc</name>
        <lei>5299000AON4Q9NT2JE42</lei>
        <title>EDITAS MEDICINE INC</title>
        <cusip>28106W103</cusip>
        <identifiers>
          <isin value="US28106W1036"/>
        </identifiers>
        <balance>27930.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>826169.40000000</valUSD>
        <pctVal>0.248758812446</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="507699.36000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Krystal Biotech Inc</name>
        <lei>549300YONUY68210OE41</lei>
        <title>KRYSTAL BIOTECH INC</title>
        <cusip>501147102</cusip>
        <identifiers>
          <isin value="US5011471027"/>
        </identifiers>
        <balance>12740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>527690.80000000</valUSD>
        <pctVal>0.158887192804</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gritstone Oncology Inc</name>
        <lei>5493003TER6KY3MUVY84</lei>
        <title>GRITSTONE ONCOLOGY INC</title>
        <cusip>39868T105</cusip>
        <identifiers>
          <isin value="US39868T1051"/>
        </identifiers>
        <balance>124698.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>827994.72000000</valUSD>
        <pctVal>0.249308414544</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3179.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CRYOPORT, INC.</name>
        <lei>N/A</lei>
        <title>CRYOPORT INC</title>
        <cusip>229050307</cusip>
        <identifiers>
          <isin value="US2290503075"/>
        </identifiers>
        <balance>155793.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4712738.25000000</valUSD>
        <pctVal>1.419000958450</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="4462018.55000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INVITAE CORPORATION</name>
        <lei>549300MYI59DZW1WIX92</lei>
        <title>INVITAE CORPORATION</title>
        <cusip>46185L103</cusip>
        <identifiers>
          <isin value="US46185L1035"/>
        </identifiers>
        <balance>58565.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1773933.85000000</valUSD>
        <pctVal>0.534129777603</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SAGE THERAPEUTICS, INC.</name>
        <lei>5493000JX4BJS9W6CN35</lei>
        <title>SAGE THERAPEUTICS INC</title>
        <cusip>78667J108</cusip>
        <identifiers>
          <isin value="US78667J1088"/>
        </identifiers>
        <balance>20370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>846984.60000000</valUSD>
        <pctVal>0.255026249164</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GODADDY INC.</name>
        <lei>N/A</lei>
        <title>GODADDY INC - CLASS A</title>
        <cusip>380237107</cusip>
        <identifiers>
          <isin value="US3802371076"/>
        </identifiers>
        <balance>44870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3290317.10000000</valUSD>
        <pctVal>0.990711317036</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ICAD, INC.</name>
        <lei>N/A</lei>
        <title>ICAD INC</title>
        <cusip>44934S206</cusip>
        <identifiers>
          <isin value="US44934S2068"/>
        </identifiers>
        <balance>18350.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>183316.50000000</valUSD>
        <pctVal>0.055196421995</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kaleido Biosciences Inc</name>
        <lei>N/A</lei>
        <title>KALEIDO BIOSCIENCES INC</title>
        <cusip>483347100</cusip>
        <identifiers>
          <isin value="US4833471000"/>
        </identifiers>
        <balance>43790.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>325359.70000000</valUSD>
        <pctVal>0.097965493021</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="221126.94000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Akouos Inc</name>
        <lei>N/A</lei>
        <title>AKOUOS INC</title>
        <cusip>00973J101</cusip>
        <identifiers>
          <isin value="US00973J1016"/>
        </identifiers>
        <balance>35000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>787500.00000000</valUSD>
        <pctVal>0.237115493265</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Atreca Inc</name>
        <lei>549300B5CQV1OOXFLU71</lei>
        <title>ATRECA INC</title>
        <cusip>04965G109</cusip>
        <identifiers>
          <isin value="US04965G1094"/>
        </identifiers>
        <balance>41935.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>892376.80000000</valUSD>
        <pctVal>0.268693796965</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="856039.29999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adaptimmune Therapeutics PLC</name>
        <lei>549300UUNWK8TRT5EW12</lei>
        <title>ADAPTIMMUNE THERAPEUTICS PLC-ADR</title>
        <cusip>00653A107</cusip>
        <identifiers>
          <isin value="US00653A1079"/>
        </identifiers>
        <balance>143670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1438136.70000000</valUSD>
        <pctVal>0.433021578417</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Allakos Inc</name>
        <lei>549300S6ZD1W6BPMDY37</lei>
        <title>ALLAKOS INC</title>
        <cusip>01671P100</cusip>
        <identifiers>
          <isin value="US01671P1003"/>
        </identifiers>
        <balance>12960.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>931305.60000000</valUSD>
        <pctVal>0.280415221237</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="289154.94000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Blueprint Medicines Corp</name>
        <lei>5299004CC60O9T5HVM83</lei>
        <title>BLUEPRINT MEDICINES CORP</title>
        <cusip>09627Y109</cusip>
        <identifiers>
          <isin value="US09627Y1091"/>
        </identifiers>
        <balance>27490.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2144220.00000000</valUSD>
        <pctVal>0.645622581548</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BLUEBIRD BIO, INC.</name>
        <lei>N/A</lei>
        <title>BLUEBIRD BIO INC</title>
        <cusip>09609G100</cusip>
        <identifiers>
          <isin value="US09609G1004"/>
        </identifiers>
        <balance>82310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5024202.40000000</valUSD>
        <pctVal>1.512782514719</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ZENDESK, INC.</name>
        <lei>549300SLI6BN94BKKO36</lei>
        <title>ZENDESK INC</title>
        <cusip>98936J101</cusip>
        <identifiers>
          <isin value="US98936J1016"/>
        </identifiers>
        <balance>26810.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2373489.30000000</valUSD>
        <pctVal>0.714655347466</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Replimune Group Inc</name>
        <lei>549300AY704NEIRC4K64</lei>
        <title>REPLIMUNE GROUP INC</title>
        <cusip>76029N106</cusip>
        <identifiers>
          <isin value="US76029N1063"/>
        </identifiers>
        <balance>85370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2121444.50000000</valUSD>
        <pctVal>0.638764900384</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GLOBAL PAYMENTS INC.</name>
        <lei>549300NOMHGVQBX6S778</lei>
        <title>GLOBAL PAYMENTS, INC.</title>
        <cusip>37940X102</cusip>
        <identifiers>
          <isin value="US37940X1028"/>
        </identifiers>
        <balance>15680.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2659641.60000000</valUSD>
        <pctVal>0.800815530023</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CytomX Therapeutics Inc</name>
        <lei>5493004VW2FW0QLL3345</lei>
        <title>CYTOMX THERAPEUTICS INC</title>
        <cusip>23284F105</cusip>
        <identifiers>
          <isin value="US23284F1057"/>
        </identifiers>
        <balance>127250.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1059992.50000000</valUSD>
        <pctVal>0.319162723168</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Marinus Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>MARINUS PHARMACEUTICALS INC</title>
        <cusip>56854Q101</cusip>
        <identifiers>
          <isin value="US56854Q1013"/>
        </identifiers>
        <balance>249860.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>634644.40000000</valUSD>
        <pctVal>0.191090818989</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>KEYSIGHT TECHNOLOGIES, INC.</name>
        <lei>549300GLKVIO8YRCYN02</lei>
        <title>KEYSIGHT TECHNOLOGIES INC</title>
        <cusip>49338L103</cusip>
        <identifiers>
          <isin value="US49338L1035"/>
        </identifiers>
        <balance>23780.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2396548.40000000</valUSD>
        <pctVal>0.721598420318</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BOINGO WIRELESS, INC.</name>
        <lei>54930058LPWPZZCRMC04</lei>
        <title>BOINGO WIRELESS, INC.</title>
        <cusip>09739C102</cusip>
        <identifiers>
          <isin value="US09739C1027"/>
        </identifiers>
        <balance>280870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3741188.40000000</valUSD>
        <pctVal>1.126468232209</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="281808.72000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NVIDIA CORPORATION</name>
        <lei>549300S4KLFTLO7GSQ80</lei>
        <title>NVIDIA CORP.</title>
        <cusip>67066G104</cusip>
        <identifiers>
          <isin value="US67066G1040"/>
        </identifiers>
        <balance>10480.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3981456.80000000</valUSD>
        <pctVal>1.198812816567</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LATTICE SEMICONDUCTOR CORPORATION</name>
        <lei>549300LRBBPZDQ2II567</lei>
        <title>LATTICE SEMICONDUCTOR</title>
        <cusip>518415104</cusip>
        <identifiers>
          <isin value="US5184151042"/>
        </identifiers>
        <balance>184760.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5245336.40000000</valUSD>
        <pctVal>1.579365749624</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Athenex Inc</name>
        <lei>5493001V4L0Q5EPPOH52</lei>
        <title>ATHENEX INC</title>
        <cusip>04685N103</cusip>
        <identifiers>
          <isin value="US04685N1037"/>
        </identifiers>
        <balance>43520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>598835.20000000</valUSD>
        <pctVal>0.180308703279</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="576894.75999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VISA INC.</name>
        <lei>549300JZ4OKEHW3DPJ59</lei>
        <title>VISA INC. - CLASS A</title>
        <cusip>92826C839</cusip>
        <identifiers>
          <isin value="US92826C8394"/>
        </identifiers>
        <balance>29550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5708173.50000000</valUSD>
        <pctVal>1.718725555679</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5588296.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Homology Medicines Inc</name>
        <lei>549300RWKPJEFTM3K452</lei>
        <title>HOMOLOGY MEDICINES INC</title>
        <cusip>438083107</cusip>
        <identifiers>
          <isin value="US4380831077"/>
        </identifiers>
        <balance>52580.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>798690.20000000</valUSD>
        <pctVal>0.240484851732</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VARONIS SYSTEMS, INC.</name>
        <lei>549300SHIVNRRH7STS26</lei>
        <title>VARONIS SYSTEMS INC</title>
        <cusip>922280102</cusip>
        <identifiers>
          <isin value="US9222801022"/>
        </identifiers>
        <balance>40500.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3583440.00000000</valUSD>
        <pctVal>1.078970340555</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="431053.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Beigene Ltd</name>
        <lei>549300JFUK6FRD5MH739</lei>
        <title>BEIGENE LTD- ADR</title>
        <cusip>07725L102</cusip>
        <identifiers>
          <isin value="US07725L1026"/>
        </identifiers>
        <balance>6450.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1215180.00000000</valUSD>
        <pctVal>0.365889530293</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FAIR ISAAC CORPORATION</name>
        <lei>RI6HET5SJUEY30V1PS26</lei>
        <title>FAIR ISAAC CORP.</title>
        <cusip>303250104</cusip>
        <identifiers>
          <isin value="US3032501047"/>
        </identifiers>
        <balance>7560.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3160382.40000000</valUSD>
        <pctVal>0.951588103725</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adaptive Biotechnologies Corp</name>
        <lei>549300ZTF7OT1FW66Q96</lei>
        <title>ADAPTIVE BIOTECHNOLOGIES</title>
        <cusip>00650F109</cusip>
        <identifiers>
          <isin value="US00650F1093"/>
        </identifiers>
        <balance>19170.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>927444.60000000</valUSD>
        <pctVal>0.279252677848</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>WIX.COM LTD</name>
        <lei>5493008P6N29Q1AG9464</lei>
        <title>WIX.COM LTD</title>
        <cusip>M98068105</cusip>
        <identifiers>
          <isin value="IL0011301780"/>
        </identifiers>
        <balance>39120.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10023326.40000000</valUSD>
        <pctVal>3.018013947297</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Myovant Sciences Ltd</name>
        <lei>N/A</lei>
        <title>MYOVANT SCIENCES LTD</title>
        <cusip>G637AM102</cusip>
        <identifiers>
          <isin value="BMG637AM1024"/>
        </identifiers>
        <balance>62970.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1298441.40000000</valUSD>
        <pctVal>0.390959457825</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>BM</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="162288.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PROOFPOINT, INC.</name>
        <lei>529900C5FODDK0WSR085</lei>
        <title>PROOFPOINT, INC.</title>
        <cusip>743424103</cusip>
        <identifiers>
          <isin value="US7434241037"/>
        </identifiers>
        <balance>28029.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3114582.48000000</valUSD>
        <pctVal>0.937797791823</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ILLUMINA, INC.</name>
        <lei>SQ95QG8SR5Q56LSNF682</lei>
        <title>ILLUMINA, INC.</title>
        <cusip>452327109</cusip>
        <identifiers>
          <isin value="US4523271090"/>
        </identifiers>
        <balance>6850.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2536897.50000000</valUSD>
        <pctVal>0.763857399462</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FACEBOOK, INC.</name>
        <lei>BQ4BKCS1HXDV9HN80Z93</lei>
        <title>FACEBOOK INC</title>
        <cusip>30303M102</cusip>
        <identifiers>
          <isin value="US30303M1027"/>
        </identifiers>
        <balance>20750.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4711702.50000000</valUSD>
        <pctVal>1.418689095120</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kura Oncology Inc</name>
        <lei>5493005QORQTZCZYOP39</lei>
        <title>KURA ONCOLOGY INC</title>
        <cusip>50127T109</cusip>
        <identifiers>
          <isin value="US50127T1097"/>
        </identifiers>
        <balance>116590.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1900417.00000000</valUSD>
        <pctVal>0.572213732527</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Stoke Therapeutics Inc</name>
        <lei>549300RD25SS2DIJHJ67</lei>
        <title>STOKE THERAPEUTICS INC</title>
        <cusip>86150R107</cusip>
        <identifiers>
          <isin value="US86150R1077"/>
        </identifiers>
        <balance>26620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>634354.60000000</valUSD>
        <pctVal>0.191003560487</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="611653.13000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>STMicroelectronics N.V.</name>
        <lei>213800Z8NOHIKRI42W10</lei>
        <title>STMICROELECTRONICS NV, NY SHARESARES</title>
        <cusip>861012102</cusip>
        <identifiers>
          <isin value="US8610121027"/>
        </identifiers>
        <balance>201740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5529693.40000000</valUSD>
        <pctVal>1.664985369076</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5297864.25000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RINGCENTRAL, INC.</name>
        <lei>549300C8EH0H1614VE84</lei>
        <title>RINGCENTRAL INC CLASS A</title>
        <cusip>76680R206</cusip>
        <identifiers>
          <isin value="US76680R2067"/>
        </identifiers>
        <balance>64060.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18257740.60000000</valUSD>
        <pctVal>5.497388150199</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TAKE-TWO INTERACTIVE SOFTWARE, INC.</name>
        <lei>BOMSTHHJK882EWYX3334</lei>
        <title>TAKE-TWO INTERACTIVE SOFTWARE</title>
        <cusip>874054109</cusip>
        <identifiers>
          <isin value="US8740541094"/>
        </identifiers>
        <balance>20270.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2829083.90000000</valUSD>
        <pctVal>0.851834443730</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LENDINGTREE, INC.</name>
        <lei>549300ISY5YHUJZTON08</lei>
        <title>LENDINGTREE INC</title>
        <cusip>52603B107</cusip>
        <identifiers>
          <isin value="US52603B1070"/>
        </identifiers>
        <balance>6330.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1832724.90000000</valUSD>
        <pctVal>0.551831706264</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1697868.75000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Twist Bioscience Corp</name>
        <lei>549300T23BL59LCOH584</lei>
        <title>TWIST BIOSCIENCE CORP</title>
        <cusip>90184D100</cusip>
        <identifiers>
          <isin value="US90184D1000"/>
        </identifiers>
        <balance>57460.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2602938.00000000</valUSD>
        <pctVal>0.783742130551</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="541929.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GOSSAMER BIO, INC.</name>
        <lei>549300ZOC0N2W6PSFR58</lei>
        <title>GOSSAMER BIO INC</title>
        <cusip>38341P102</cusip>
        <identifiers>
          <isin value="US38341P1021"/>
        </identifiers>
        <balance>80980.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1052740.00000000</valUSD>
        <pctVal>0.316979002387</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="778238.75999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kezar Life Sciences Inc</name>
        <lei>549300EV1V8GXBV18004</lei>
        <title>KEZAR LIFE SCIENCES INC</title>
        <cusip>49372L100</cusip>
        <identifiers>
          <isin value="US49372L1008"/>
        </identifiers>
        <balance>332406.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1721863.08000000</valUSD>
        <pctVal>0.518451318793</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Springworks Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>SPRINGWORKS THERAPEUTICS INC</title>
        <cusip>85205L107</cusip>
        <identifiers>
          <isin value="US85205L1070"/>
        </identifiers>
        <balance>24240.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1018080.00000000</valUSD>
        <pctVal>0.306542909693</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="864486.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>10X Genomics Inc</name>
        <lei>5493003Z6741WNLG7H43</lei>
        <title>10X GENOMICS INC</title>
        <cusip>88025U109</cusip>
        <identifiers>
          <isin value="US88025U1097"/>
        </identifiers>
        <balance>25890.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2312235.90000000</valUSD>
        <pctVal>0.696212007586</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Generation Bio Co</name>
        <lei>N/A</lei>
        <title>GENERATION BIO CO</title>
        <cusip>37148K100</cusip>
        <identifiers>
          <isin value="US37148K1007"/>
        </identifiers>
        <balance>45470.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>954870.00000000</valUSD>
        <pctVal>0.287510439434</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirati Therapeutics Inc</name>
        <lei>529900GYRW59IDQV6N54</lei>
        <title>MIRATI THERAPEUTICS INC</title>
        <cusip>60468T105</cusip>
        <identifiers>
          <isin value="US60468T1051"/>
        </identifiers>
        <balance>14260.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1628064.20000000</valUSD>
        <pctVal>0.490208566159</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Celyad Oncology</name>
        <lei>549300ORR0M8XF56OI64</lei>
        <title>CELYAD -SPON ADR</title>
        <cusip>151205200</cusip>
        <identifiers>
          <isin value="US1512052002"/>
        </identifiers>
        <balance>50610.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>549624.60000000</valUSD>
        <pctVal>0.165491438907</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>BE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MATCH GROUP, INC.</name>
        <lei>549300BIJKT86CPCKK96</lei>
        <title>MATCH GROUP INC</title>
        <cusip>57665R106</cusip>
        <identifiers>
          <isin value="US57665R1068"/>
        </identifiers>
        <balance>38760.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4149258.00000000</valUSD>
        <pctVal>1.249337596642</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3580044.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bicycle Therapeutics PLC</name>
        <lei>N/A</lei>
        <title>BICYCLE THERAPEUTICS LTD-ADR</title>
        <cusip>088786108</cusip>
        <identifiers>
          <isin value="US0887861088"/>
        </identifiers>
        <balance>81519.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1263544.50000000</valUSD>
        <pctVal>0.380452034768</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="418363.81000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lyra Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>LYRA THERAPEUTICS INC</title>
        <cusip>55234L105</cusip>
        <identifiers>
          <isin value="US55234L1052"/>
        </identifiers>
        <balance>29550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>335097.00000000</valUSD>
        <pctVal>0.100897384694</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="325597.01999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Iovance Biotherapeutics Inc</name>
        <lei>N/A</lei>
        <title>IOVANCE BIOTHERAPEUTICS INC</title>
        <cusip>462260100</cusip>
        <identifiers>
          <isin value="US4622601007"/>
        </identifiers>
        <balance>64560.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1772172.00000000</valUSD>
        <pctVal>0.533599286261</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ascendis Pharma A/S</name>
        <lei>549300B66JN3W3J8GH73</lei>
        <title>ASCENDIS PHARMA A/S - ADR</title>
        <cusip>04351P101</cusip>
        <identifiers>
          <isin value="US04351P1012"/>
        </identifiers>
        <balance>13190.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1950801.00000000</valUSD>
        <pctVal>0.587384306511</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Provention Bio Inc</name>
        <lei>5493003LM26XAVJKLD34</lei>
        <title>PROVENTION BIO INC</title>
        <cusip>74374N102</cusip>
        <identifiers>
          <isin value="US74374N1028"/>
        </identifiers>
        <balance>68400.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>965124.00000000</valUSD>
        <pctVal>0.290597908980</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="244530.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Turning Point Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>TURNING POINT THERAPEUTICS INC</title>
        <cusip>90041T108</cusip>
        <identifiers>
          <isin value="US90041T1088"/>
        </identifiers>
        <balance>16040.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1036023.60000000</valUSD>
        <pctVal>0.311945710410</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Matinas BioPharma Holdings Inc</name>
        <lei>549300TGHXVKQ7EJRO41</lei>
        <title>MATINAS BIOPHARMA HOLDINGS INC</title>
        <cusip>576810105</cusip>
        <identifiers>
          <isin value="US5768101058"/>
        </identifiers>
        <balance>712390.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>550677.47000000</valUSD>
        <pctVal>0.165808457052</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="487778.35000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AVROBIO Inc</name>
        <lei>N/A</lei>
        <title>AVROBIO INC</title>
        <cusip>05455M100</cusip>
        <identifiers>
          <isin value="US05455M1009"/>
        </identifiers>
        <balance>66310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1157109.50000000</valUSD>
        <pctVal>0.348404558545</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fusion Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>FUSION PHARMACEUTICALS INC</title>
        <cusip>36118A100</cusip>
        <identifiers>
          <isin value="CA36118A1003"/>
        </identifiers>
        <balance>48890.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>854108.30000000</valUSD>
        <pctVal>0.257171188389</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fate Therapeutics Inc</name>
        <lei>549300L14Q4UHOODLA90</lei>
        <title>FATE THERAPEUTICS INC</title>
        <cusip>31189P102</cusip>
        <identifiers>
          <isin value="US31189P1021"/>
        </identifiers>
        <balance>150360.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5158851.60000000</valUSD>
        <pctVal>1.553325259450</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VIAVI SOLUTIONS INC.</name>
        <lei>5493006K3E3N1QOBF092</lei>
        <title>VIAVI SOLUTIONS INC</title>
        <cusip>925550105</cusip>
        <identifiers>
          <isin value="US9255501051"/>
        </identifiers>
        <balance>200980.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2560485.20000000</valUSD>
        <pctVal>0.770959633265</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="260023.74000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EURONET WORLDWIDE, INC.</name>
        <lei>YG3575C4DSHJPA5KET68</lei>
        <title>EURONET WORLDWIDE INC</title>
        <cusip>298736109</cusip>
        <identifiers>
          <isin value="US2987361092"/>
        </identifiers>
        <balance>14600.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1398972.00000000</valUSD>
        <pctVal>0.421229124881</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DermTech Inc</name>
        <lei>N/A</lei>
        <title>DERMTECH INC</title>
        <cusip>24984K105</cusip>
        <identifiers>
          <isin value="US24984K1051"/>
        </identifiers>
        <balance>307692.50000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4070771.78000000</valUSD>
        <pctVal>1.225705471220</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NEUROCRINE BIOSCIENCES, INC.</name>
        <lei>549300FECER0XBN49756</lei>
        <title>NEUROCRINE BIOSCIENCES INC</title>
        <cusip>64125C109</cusip>
        <identifiers>
          <isin value="US64125C1099"/>
        </identifiers>
        <balance>6300.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>768600.00000000</valUSD>
        <pctVal>0.231424721427</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MICROSOFT CORPORATION</name>
        <lei>INR2EJN1ERAN0W5ZP974</lei>
        <title>MICROSOFT CORP.</title>
        <cusip>594918104</cusip>
        <identifiers>
          <isin value="US5949181045"/>
        </identifiers>
        <balance>75810.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15428093.10000000</valUSD>
        <pctVal>4.645384007049</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMMUNOMEDICS, INC.</name>
        <lei>5493007ZU7DDO8PSIM59</lei>
        <title>IMMUNOMEDICS INC</title>
        <cusip>452907108</cusip>
        <identifiers>
          <isin value="US4529071080"/>
        </identifiers>
        <balance>38230.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1354871.20000000</valUSD>
        <pctVal>0.407950416379</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Albireo Pharma Inc</name>
        <lei>549300835H8LC7O8VC29</lei>
        <title>ALBIREO PHARMA INC</title>
        <cusip>01345P106</cusip>
        <identifiers>
          <isin value="US01345P1066"/>
        </identifiers>
        <balance>23820.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>630991.80000000</valUSD>
        <pctVal>0.189991024639</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EPIZYME, INC.</name>
        <lei>549300TNFWF88O4U4605</lei>
        <title>EPIZYME INC</title>
        <cusip>29428V104</cusip>
        <identifiers>
          <isin value="US29428V1044"/>
        </identifiers>
        <balance>116510.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1871150.60000000</valUSD>
        <pctVal>0.563401647610</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MONOLITHIC POWER SYSTEMS, INC.</name>
        <lei>529900TB7O85LSZ1XU31</lei>
        <title>MONOLITHIC POWER SYSTEMS INC</title>
        <cusip>609839105</cusip>
        <identifiers>
          <isin value="US6098391054"/>
        </identifiers>
        <balance>13120.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3109440.00000000</valUSD>
        <pctVal>0.936249396037</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TWITTER, INC.</name>
        <lei>549300I8RX485XMK6836</lei>
        <title>TWITTER INC</title>
        <cusip>90184L102</cusip>
        <identifiers>
          <isin value="US90184L1026"/>
        </identifiers>
        <balance>68030.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2026613.70000000</valUSD>
        <pctVal>0.610211437630</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Airgain Inc</name>
        <lei>549300LL8ZO53X8A5U98</lei>
        <title>AIRGAIN INC</title>
        <cusip>00938A104</cusip>
        <identifiers>
          <isin value="US00938A1043"/>
        </identifiers>
        <balance>92078.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>988917.72000000</valUSD>
        <pctVal>0.297762175208</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="948829.79999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PAYCOM SOFTWARE, INC.</name>
        <lei>254900LSB0HNJUDC6Q18</lei>
        <title>PAYCOM SOFTWARE INC</title>
        <cusip>70432V102</cusip>
        <identifiers>
          <isin value="US70432V1026"/>
        </identifiers>
        <balance>13740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4255690.20000000</valUSD>
        <pctVal>1.281384229787</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sutro Biopharma Inc</name>
        <lei>5493005U6P15VD25P851</lei>
        <title>SUTRO BIOPHARMA INC</title>
        <cusip>869367102</cusip>
        <identifiers>
          <isin value="US8693671021"/>
        </identifiers>
        <balance>62190.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>482594.40000000</valUSD>
        <pctVal>0.145308710099</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="484540.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Passage Bio Inc</name>
        <lei>N/A</lei>
        <title>PASSAGE BIO INC</title>
        <cusip>702712100</cusip>
        <identifiers>
          <isin value="US7027121000"/>
        </identifiers>
        <balance>20550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>561631.50000000</valUSD>
        <pctVal>0.169106704959</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="564546.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>COHU, INC.</name>
        <lei>529900FJPORJ3JJ2XS33</lei>
        <title>COHU, INC.</title>
        <cusip>192576106</cusip>
        <identifiers>
          <isin value="US1925761066"/>
        </identifiers>
        <balance>213740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3706251.60000000</valUSD>
        <pctVal>1.115948795301</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MyoKardia Inc</name>
        <lei>549300OLNNNZ1NI9UY54</lei>
        <title>MYOKARDIA INC</title>
        <cusip>62857M105</cusip>
        <identifiers>
          <isin value="US62857M1053"/>
        </identifiers>
        <balance>12950.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1251229.00000000</valUSD>
        <pctVal>0.376743849553</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MARVELL TECHNOLOGY GROUP LTD.</name>
        <lei>8DF36O58U3QIHUCGZB18</lei>
        <title>MARVELL TECHNOLOGY GROUP LIMITED</title>
        <cusip>G5876H105</cusip>
        <identifiers>
          <isin value="BMG5876H1051"/>
        </identifiers>
        <balance>123560.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4332013.60000000</valUSD>
        <pctVal>1.304365132186</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>BM</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ASSEMBLY BIOSCIENCES, INC.</name>
        <lei>N/A</lei>
        <title>ASSEMBLY BIOSCIENCES INC</title>
        <cusip>045396108</cusip>
        <identifiers>
          <isin value="US0453961080"/>
        </identifiers>
        <balance>82630.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1926931.60000000</valUSD>
        <pctVal>0.580197253108</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AVAYA HOLDINGS CORP.</name>
        <lei>549300NZS2OZN6Q63A60</lei>
        <title>AVAYA HOLDINGS CORP</title>
        <cusip>05351X101</cusip>
        <identifiers>
          <isin value="US05351X1019"/>
        </identifiers>
        <balance>172460.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2131605.60000000</valUSD>
        <pctVal>0.641824397830</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arco Platform Ltd</name>
        <lei>N/A</lei>
        <title>ARCO PLATFORM LTD</title>
        <cusip>G04553106</cusip>
        <identifiers>
          <isin value="KYG045531061"/>
        </identifiers>
        <balance>49910.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2170086.80000000</valUSD>
        <pctVal>0.653411050172</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Exagen Inc</name>
        <lei>549300JV2CYDOME5OO17</lei>
        <title>EXAGEN INC</title>
        <cusip>30068X103</cusip>
        <identifiers>
          <isin value="US30068X1037"/>
        </identifiers>
        <balance>81012.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1005358.92000000</valUSD>
        <pctVal>0.302712604729</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="74750.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SERVICENOW, INC.</name>
        <lei>549300HJTQM36M0E1G39</lei>
        <title>SERVICENOW INC</title>
        <cusip>81762P102</cusip>
        <identifiers>
          <isin value="US81762P1021"/>
        </identifiers>
        <balance>18370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7440952.20000000</valUSD>
        <pctVal>2.240463557165</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Scholar Rock Holding Corp</name>
        <lei>549300Z1FLPGL4OWJ459</lei>
        <title>SCHOLAR ROCK HOLDING CORP</title>
        <cusip>80706P103</cusip>
        <identifiers>
          <isin value="US80706P1030"/>
        </identifiers>
        <balance>49670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>904490.70000000</valUSD>
        <pctVal>0.272341280615</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="637657.27999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aimmune Therapeutics Inc</name>
        <lei>549300WDF7T2EVBC1877</lei>
        <title>AIMMUNE THERAPEUTICS INC</title>
        <cusip>00900T107</cusip>
        <identifiers>
          <isin value="US00900T1079"/>
        </identifiers>
        <balance>91620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1530970.20000000</valUSD>
        <pctVal>0.460973656060</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1251401.47000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oric Pharmaceuticals Inc</name>
        <lei>54930033FJRNEYBW0L25</lei>
        <title>ORIC PHARMACEUTICALS INC</title>
        <cusip>68622P109</cusip>
        <identifiers>
          <isin value="US68622P1093"/>
        </identifiers>
        <balance>25870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>872595.10000000</valUSD>
        <pctVal>0.262737546104</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="875640.09000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMICUS THERAPEUTICS, INC.</name>
        <lei>549300MRD1SMUTNBPQ53</lei>
        <title>AMICUS THERAPEUTICS, INC.</title>
        <cusip>03152W109</cusip>
        <identifiers>
          <isin value="US03152W1099"/>
        </identifiers>
        <balance>71640.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1080331.20000000</valUSD>
        <pctVal>0.325286686194</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DOLBY LABORATORIES, INC.</name>
        <lei>549300X04FB2QPCJ5J24</lei>
        <title>DOLBY LABORATORIES INC</title>
        <cusip>25659T107</cusip>
        <identifiers>
          <isin value="US25659T1079"/>
        </identifiers>
        <balance>34410.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2266586.70000000</valUSD>
        <pctVal>0.682467077332</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>APELLIS PHARMACEUTICALS, INC.</name>
        <lei>254900HS0ZFRXXSB9D42</lei>
        <title>APELLIS PHARMACEUTICALS INC</title>
        <cusip>03753U106</cusip>
        <identifiers>
          <isin value="US03753U1060"/>
        </identifiers>
        <balance>73603.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2403873.98000000</valUSD>
        <pctVal>0.723804145416</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rapt Therapeutics Inc</name>
        <lei>549300MB473BIU78ES48</lei>
        <title>RAPT THERAPEUTICS INC</title>
        <cusip>75382E109</cusip>
        <identifiers>
          <isin value="US75382E1091"/>
        </identifiers>
        <balance>20900.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>606518.00000000</valUSD>
        <pctVal>0.182621986976</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="549822.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GW PHARMACEUTICALS PLC</name>
        <lei>213800ISBN5CNUZMHZ39</lei>
        <title>GW PHARMACEUTICALS PLC</title>
        <cusip>36197T103</cusip>
        <identifiers>
          <isin value="US36197T1034"/>
        </identifiers>
        <balance>15740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1931612.80000000</valUSD>
        <pctVal>0.581606757929</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1899757.44000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MKS INSTRUMENTS, INC.</name>
        <lei>549300KEQATBHAGVF505</lei>
        <title>MKS INSTRUMENTS, INC.</title>
        <cusip>55306N104</cusip>
        <identifiers>
          <isin value="US55306N1046"/>
        </identifiers>
        <balance>34530.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3910177.20000000</valUSD>
        <pctVal>1.177350597502</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Constellation Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>CONSTELLATION PHARMACEUTICALS INC</title>
        <cusip>210373106</cusip>
        <identifiers>
          <isin value="US2103731061"/>
        </identifiers>
        <balance>28550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>857927.50000000</valUSD>
        <pctVal>0.258321145839</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dropbox Inc</name>
        <lei>549300JCDF7UAR6TJR51</lei>
        <title>DROPBOX INC</title>
        <cusip>26210C104</cusip>
        <identifiers>
          <isin value="US26210C1045"/>
        </identifiers>
        <balance>145070.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3158173.90000000</valUSD>
        <pctVal>0.950923126497</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LUMENTUM HOLDINGS INC.</name>
        <lei>549300JLWRRC38DWEF52</lei>
        <title>LUMENTUM HOLDINGS INC</title>
        <cusip>55024U109</cusip>
        <identifiers>
          <isin value="US55024U1097"/>
        </identifiers>
        <balance>45570.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3710765.10000000</valUSD>
        <pctVal>1.117307805814</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Allogene Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>ALLOGENE THERAPEUTICS INC</title>
        <cusip>019770106</cusip>
        <identifiers>
          <isin value="US0197701065"/>
        </identifiers>
        <balance>34910.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1494846.20000000</valUSD>
        <pctVal>0.450096754373</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="475529.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LAM RESEARCH CORPORATION</name>
        <lei>549300I4GMO6D34U1T02</lei>
        <title>LAM RESEARCH CORP.</title>
        <cusip>512807108</cusip>
        <identifiers>
          <isin value="US5128071082"/>
        </identifiers>
        <balance>18220.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5893441.20000000</valUSD>
        <pctVal>1.774509482119</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>QUOTIENT LIMITED</name>
        <lei>549300BOTHGGT8D81659</lei>
        <title>QUOTIENT LTD</title>
        <cusip>G73268107</cusip>
        <identifiers>
          <isin value="JE00BLG2ZQ72"/>
        </identifiers>
        <balance>111620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>825988.00000000</valUSD>
        <pctVal>0.248704193081</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>JE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="768943.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Centogene NV</name>
        <lei>724500ZPEHPCLDLVV439</lei>
        <title>CENTOGENE NV</title>
        <cusip>N1976T109</cusip>
        <identifiers>
          <isin value="NL0014040206"/>
        </identifiers>
        <balance>50310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1151092.80000000</valUSD>
        <pctVal>0.346592935957</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TWILIO INC.</name>
        <lei>5493004W8TRGD63APX93</lei>
        <title>TWILIO INC</title>
        <cusip>90138F102</cusip>
        <identifiers>
          <isin value="US90138F1021"/>
        </identifiers>
        <balance>41150.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9029133.00000000</valUSD>
        <pctVal>2.718663269910</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="4831671.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FABRINET</name>
        <lei>5493004TETZ6IYF7CV44</lei>
        <title>FABRINET</title>
        <cusip>G3323L100</cusip>
        <identifiers>
          <isin value="KYG3323L1005"/>
        </identifiers>
        <balance>56250.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3511125.00000000</valUSD>
        <pctVal>1.057196363544</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avidity Biosciences Inc</name>
        <lei>N/A</lei>
        <title>AVIDITY BIOSCIENCES INC</title>
        <cusip>05370A108</cusip>
        <identifiers>
          <isin value="US05370A1088"/>
        </identifiers>
        <balance>48000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1356480.00000000</valUSD>
        <pctVal>0.408434824513</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NEOGENOMICS, INC.</name>
        <lei>N/A</lei>
        <title>NEOGENOMICS INC</title>
        <cusip>64049M209</cusip>
        <identifiers>
          <isin value="US64049M2098"/>
        </identifiers>
        <balance>63530.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1968159.40000000</valUSD>
        <pctVal>0.592610904071</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Crinetics Pharmaceuticals Inc</name>
        <lei>549300Q1CNFXK5P31D28</lei>
        <title>CRINETICS PHARMACEUTICALS INC</title>
        <cusip>22663K107</cusip>
        <identifiers>
          <isin value="US22663K1079"/>
        </identifiers>
        <balance>36238.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>634889.76000000</valUSD>
        <pctVal>0.191164696649</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="641445.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Equillium Inc</name>
        <lei>549300OC7SSPSNNGHE64</lei>
        <title>EQUILLIUM INC</title>
        <cusip>29446K106</cusip>
        <identifiers>
          <isin value="US29446K1060"/>
        </identifiers>
        <balance>210460.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>620857.00000000</valUSD>
        <pctVal>0.186939446098</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MacroGenics Inc</name>
        <lei>5493001KJQUA83L8MH79</lei>
        <title>MACROGENICS INC</title>
        <cusip>556099109</cusip>
        <identifiers>
          <isin value="US5560991094"/>
        </identifiers>
        <balance>44170.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1233226.40000000</valUSD>
        <pctVal>0.371323283992</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1190672.83999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Beam Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>BEAM THERAPEUTICS INC</title>
        <cusip>07373V105</cusip>
        <identifiers>
          <isin value="US07373V1052"/>
        </identifiers>
        <balance>36290.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1016120.00000000</valUSD>
        <pctVal>0.305952755577</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="945035.89999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Precision BioSciences Inc</name>
        <lei>549300I5QGRS3BLHZH41</lei>
        <title>PRECISION BIOSCIENCES INC</title>
        <cusip>74019P108</cusip>
        <identifiers>
          <isin value="US74019P1084"/>
        </identifiers>
        <balance>113560.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>945954.80000000</valUSD>
        <pctVal>0.284826081281</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="477421.30000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EXACT SCIENCES CORPORATION</name>
        <lei>549300VM3X1FYD4N9Z14</lei>
        <title>EXACT SCIENCES CORP</title>
        <cusip>30063P105</cusip>
        <identifiers>
          <isin value="US30063P1057"/>
        </identifiers>
        <balance>20820.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1810090.80000000</valUSD>
        <pctVal>0.545016600504</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VEEVA SYSTEMS INC.</name>
        <lei>549300YZEXPDB92M2F02</lei>
        <title>VEEVA SYSTEMS INC</title>
        <cusip>922475108</cusip>
        <identifiers>
          <isin value="US9224751084"/>
        </identifiers>
        <balance>16620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3896060.40000000</valUSD>
        <pctVal>1.173100042587</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>COUPA SOFTWARE INCORPORATED</name>
        <lei>549300Q95ICR2GFL2K37</lei>
        <title>COUPA SOFTWARE INC</title>
        <cusip>22266L106</cusip>
        <identifiers>
          <isin value="US22266L1061"/>
        </identifiers>
        <balance>24860.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6887214.40000000</valUSD>
        <pctVal>2.073733637690</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BOOKING HOLDINGS INC.</name>
        <lei>FXM8FAOHMYDIPD38UZ17</lei>
        <title>BOOKING HOLDINGS INC</title>
        <cusip>09857L108</cusip>
        <identifiers>
          <isin value="US09857L1089"/>
        </identifiers>
        <balance>1220.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1942654.80000000</valUSD>
        <pctVal>0.584931493519</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Surface Oncology Inc</name>
        <lei>549300FCSG6MNIMFH738</lei>
        <title>SURFACE ONCOLOGY INC</title>
        <cusip>86877M209</cusip>
        <identifiers>
          <isin value="US86877M2098"/>
        </identifiers>
        <balance>325920.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2138035.20000000</valUSD>
        <pctVal>0.643760344211</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Domo Inc</name>
        <lei>N/A</lei>
        <title>DOMO INC</title>
        <cusip>257554105</cusip>
        <identifiers>
          <isin value="US2575541055"/>
        </identifiers>
        <balance>105370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3389752.90000000</valUSD>
        <pctVal>1.020651340865</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zymeworks Inc</name>
        <lei>894500AHOYAGYLYZJL67</lei>
        <title>ZYMEWORKS INC</title>
        <cusip>98985W102</cusip>
        <identifiers>
          <isin value="CA98985W1023"/>
        </identifiers>
        <balance>41870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1510250.90000000</valUSD>
        <pctVal>0.454735094740</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ROGERS CORPORATION</name>
        <lei>PW0CN80KNFR7RUOOKJ84</lei>
        <title>ROGERS CORP</title>
        <cusip>775133101</cusip>
        <identifiers>
          <isin value="US7751331015"/>
        </identifiers>
        <balance>17990.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2241554.00000000</valUSD>
        <pctVal>0.674929755417</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="24168.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BridgeBio Pharma, Inc.</name>
        <lei>54930028YG89VTY2J114</lei>
        <title>BRIDGEBIO PHARMA INC</title>
        <cusip>10806X102</cusip>
        <identifiers>
          <isin value="US10806X1028"/>
        </identifiers>
        <balance>40333.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1315259.13000000</valUSD>
        <pctVal>0.396023260167</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="818237.12999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMAZON.COM, INC.</name>
        <lei>ZXTILKJKG63JELOEG630</lei>
        <title>AMAZON.COM, INC.</title>
        <cusip>023135106</cusip>
        <identifiers>
          <isin value="US0231351067"/>
        </identifiers>
        <balance>3500.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9655870.00000000</valUSD>
        <pctVal>2.907373178358</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ADVERUM BIOTECHNOLOGIES, INC.</name>
        <lei>529900ZEDOOZL1EWHJ89</lei>
        <title>ADVERUM BIOTECHNOLOGIES INC</title>
        <cusip>00773U108</cusip>
        <identifiers>
          <isin value="US00773U1088"/>
        </identifiers>
        <balance>65990.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1377871.20000000</valUSD>
        <pctVal>0.414875694278</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DOCUSIGN, INC.</name>
        <lei>549300Q7PVDWRZ39JG09</lei>
        <title>DOCUSIGN INC</title>
        <cusip>256163106</cusip>
        <identifiers>
          <isin value="US2561631068"/>
        </identifiers>
        <balance>43340.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7463581.40000000</valUSD>
        <pctVal>2.247277187540</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eidos Therapeutics Inc</name>
        <lei>549300VGYGU07QRG6271</lei>
        <title>EIDOS THERAPEUTICS INC</title>
        <cusip>28249H104</cusip>
        <identifiers>
          <isin value="US28249H1041"/>
        </identifiers>
        <balance>26910.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1282799.70000000</valUSD>
        <pctVal>0.386249756985</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1042778.79999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FIDELITY GOVERNMENT PORTFOLIO</name>
        <lei>N/A</lei>
        <title>FIDELITY GOVERNMENT PORTFOLIO FRGXX 1.51% 2/11/2020 - Extendable</title>
        <cusip>1849969A6</cusip>
        <identifiers>
          <ticker value="FRGXX"/>
        </identifiers>
        <balance>24546569.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>24546569.14000000</valUSD>
        <pctVal>7.390948380451</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="24546569.14000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BLACKROCK LIQUIDITY FUNDS TEMPFUND PORTFOLIO</name>
        <lei>N/A</lei>
        <title>Blackrock Liquidity Funds Temp Fund Portfolio - TMPXX 1.67% 1/30/2020 - Extendable</title>
        <cusip>09248U619</cusip>
        <identifiers>
          <ticker value="TMPXX"/>
        </identifiers>
        <balance>811036.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>811036.38999999</valUSD>
        <pctVal>0.244202277677</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="811036.38999999" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MORGAN STANLEY INSTITUTIONAL LIQUIDITY FUNDS - PRIME PORTFOL</name>
        <lei>N/A</lei>
        <title>Morgan Stanley Institutional Liquidity Fund - MPFXX 2.0073% 6/18/2018 - Extendable</title>
        <cusip>61747C715</cusip>
        <identifiers>
          <ticker value="MPFXX"/>
        </identifiers>
        <balance>14510700.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14510699.62999999</valUSD>
        <pctVal>4.369157714786</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="14510699.62999999" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GOLDMAN SACHS FINANCIAL SQUARE PRIME OBLIGATIONS FUND</name>
        <lei>N/A</lei>
        <title>Goldman Sachs Financial Sq Prime Obligations- FPOXX Victory 1.62% 2/28/2018 - Extendable</title>
        <cusip>38141W364</cusip>
        <identifiers>
          <ticker value="FPOXX"/>
        </identifiers>
        <balance>5639929.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5639928.74999999</valUSD>
        <pctVal>1.698177127032</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="5639928.74999999" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JPMORGAN PRIME MONEY MARKET FUND</name>
        <lei>N/A</lei>
        <title>JPMorgan Prime Money Market Fund - CJPXX 1.67% 1/31/2020 - Extendable</title>
        <cusip>4812A0367</cusip>
        <identifiers>
          <ticker value="CJPXX"/>
        </identifiers>
        <balance>3227329.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3227328.75000000</valUSD>
        <pctVal>0.971745585379</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="3227328.75000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <explntrNotes>
      <explntrNote note="Monthly total returns reported under item B.5.a do not include any sales or redemption charges, as applicable." noteItem="B.5.a"/>
    </explntrNotes>
    <signature>
      <ncom:dateSigned>2020-07-30</ncom:dateSigned>
      <ncom:nameOfApplicant>Victory Portfolios</ncom:nameOfApplicant>
      <ncom:signature>Allan Shaer</ncom:signature>
      <ncom:signerName>Allan Shaer</ncom:signerName>
      <ncom:title>Treasurer</ncom:title>
    </signature>
  </formData>
</edgarSubmission>
